Menu

• Ask a Health Expert about METAMORPHOPSIA
• Post Your Side Effect related to METAMORPHOPSIA
• METAMORPHOPSIA and FDA Warnings
• METAMORPHOPSIA in Patients Wiki
• Report METAMORPHOPSIA in Drug Side Effect Survey

METAMORPHOPSIA side effect

What is METAMORPHOPSIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Viagra Side Effects Report #5603254-9
Consumer or non-health professional from JAPAN reported VIAGRA problem on Jan 18, 2008. Male patient, 67 years of age, was diagnosed with atrial fibrillation, cardiomegaly and was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: metamorphopsia, overdose, polypoidal choroidal vasculopathy, retinal detachment, retinal haemorrhage, visual acuity reduced, . VIAGRA dosage: unknown. During the same period patient was treated with WARFARIN, ANTICOAGULANTS, METILDIGOXIN. Patient was hospitalized and became disabled. Patient recovered.

Viagra Side Effects Report #5532491-7
VIAGRA problem was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2007. Male patient, 67 years of age, was diagnosed with atrial fibrillation and was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: metamorphopsia, overdose, polypoidal choroidal vasculopathy, retinal detachment, retinal haemorrhage, visual acuity reduced, . VIAGRA dosage: unknown. During the same period patient was treated with ANTICOAGULANTS. Patient recovered.

Lucentis Side Effects Report #5513571-9
Physician from SWITZERLAND reported LUCENTIS problem on Nov 12, 2007. Male patient, 70 years of age, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: metamorphopsia, vision blurred, visual disturbance, . LUCENTIS dosage: 0.1 ML, UNK. Patient recovered.

Lucentis Side Effects Report #5492052-5
LUCENTIS problem was reported by a Physician from SWITZERLAND on Oct 09, 2007. Male patient, 70 years of age, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: metamorphopsia, vision blurred, visual disturbance, . LUCENTIS dosage: 0.1 ML, UNK. Patient recovered.


Izilox Side Effects Report #5446011-9
Physician from FRANCE reported IZILOX problem on Aug 31, 2007. Male patient, 81 years of age, was diagnosed with unevaluable event and was treated with IZILOX. After drug was administered, patient experienced the following problems/side effects: maculopathy, metamorphopsia, visual acuity reduced, . IZILOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. Patient recovered.

Xalatan Side Effects Report #5733610-X
XALATAN problem was reported by a Health Professional from FRANCE on Apr 28, 2008. Female patient, 50 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: macular hole, metamorphopsia, pain, . XALATAN dosage: unknown. Patient recovered.

Izilox Side Effects Report #5290412-9
Physician from FRANCE reported IZILOX problem on Mar 26, 2007. Male patient, 81 years of age, was diagnosed with unevaluable event and was treated with IZILOX. After drug was administered, patient experienced the following problems/side effects: maculopathy, metamorphopsia, visual acuity reduced, . IZILOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. Patient recovered.

Izilox Side Effects Report #5293101-X
IZILOX problem was reported by a Physician from FRANCE on Mar 26, 2007. Male patient, 81 years of age, was diagnosed with unevaluable event and was treated with IZILOX. After drug was administered, patient experienced the following problems/side effects: maculopathy, metamorphopsia, visual acuity reduced, . IZILOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. Patient recovered.

Avastin Side Effects Report #5302723-9
Health Professional from GERMANY reported AVASTIN problem on Apr 11, 2007. Male patient, 75 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium, metamorphopsia, . AVASTIN dosage: 1 MG, UNK. Patient recovered.


Moxifloxacin Side Effects Report #5254923-4
MOXIFLOXACIN HYDROCHLORIDE problem was reported by a Health Professional from FRANCE on Feb 21, 2007. Male patient, 81 years of age, was diagnosed with unevaluable event and was treated with MOXIFLOXACIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: maculopathy, metamorphopsia, visual acuity reduced, . MOXIFLOXACIN HYDROCHLORIDE dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. Patient recovered.

Moxifloxacin Side Effects Report #5256193-X
Health Professional from FRANCE reported MOXIFLOXACIN HYDROCHLORIDE problem on Feb 21, 2007. Male patient, 81 years of age, was diagnosed with unevaluable event and was treated with MOXIFLOXACIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: maculopathy, metamorphopsia, visual acuity reduced, . MOXIFLOXACIN HYDROCHLORIDE dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. Patient recovered.

Visudyne Side Effects Report #5615572-9
VISUDYNE problem was reported by a Health Professional from TURKEY on Jan 17, 2008. Female patient, 48 years of age, was diagnosed with chorioretinopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: choroidal neovascularisation, disease progression, metamorphopsia, visual acuity reduced, . VISUDYNE dosage: 6 MG/M^2 ONCE IV. Patient recovered.

Visudyne Side Effects Report #5622169-3
Physician from KOREA, REPUBLIC OF reported VISUDYNE problem on Jan 23, 2008. Female patient, 15 years of age, was diagnosed with haemangioma and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: arterial disorder, macular oedema, metamorphopsia, retinal cyst, retinal exudates, . VISUDYNE dosage: 6 MG/M^2 ONCE IV. Patient recovered.

Visudyne Side Effects Report #5397733-X
VISUDYNE problem was reported by a Physician from JAPAN on July 06, 2007. Male patient, 54 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinopathy, maculopathy, metamorphopsia, retinal pigment epitheliopathy, venous occlusion, visual acuity reduced, . VISUDYNE dosage: unknown. Patient recovered.


Visudyne Side Effects Report #5397733-X
Physician from JAPAN reported VISUDYNE problem on July 06, 2007. Male patient, 54 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinopathy, maculopathy, metamorphopsia, retinal pigment epitheliopathy, venous occlusion, visual acuity reduced, . VISUDYNE dosage: unknown. Patient recovered.

Advair Side Effects Report #5307243-3
ADVAIR DISKUS problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Female patient, 52 years of age, weighting 194.4 lb, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium, eye disorder, metamorphopsia, retinal haemorrhage, vision blurred, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with NASONEX. Patient recovered.

Advair Side Effects Report #5266207-9
Consumer or non-health professional from UNITED STATES reported ADVAIR DISKUS problem on Mar 08, 2007. Female patient, 52 years of age, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium, eye disorder, metamorphopsia, retinal haemorrhage, vision blurred, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with NASONEX. Patient recovered.